Triplet Chemotherapy (FOLFOXIRI) Plus Bevacizumab Versus Doublet Chemotherapy (FOLFOX/FOLFIRI) Plus Bevacizumab in Conversion Therapy for Metastatic Colorectal Cancer: a Meta-AnalysisLin Shui, Pixian Shui, Yushen Wu et al.|Cellular Physiology and Biochemistry|2018Cited by 27